a Abtrace, a healthcare technology startup created in 2018 with operations in Portugal and the United Kingdom, announced Thursday that it has successfully closed a €2.4 million loan.
“This funding will allow Abtrace to transform what is now a data-driven tool that monitors and automates compliance with clinical practice guidelines and avoids multiple doctor visits, into a smart platform that tracks a patient’s journey in primary care in real time, starting with Omar Naim Ahmed, Abtrace CEO, said, In a statement, managing and monitoring pre-existing cases for early detection of new diseases Minute News He has access.
This funding includes a €1.3 million round of capital led by Portuguese venture capital firm Faber, with participation from Ganexa Capital and funding from UK innovation agency INNOVATE-UK.
Abtrace uses data stored in electronic health records, along with artificial intelligence tools, to simplify and improve clinical decisions in primary care, according to the same release.
Read also: A unique portrait of Jane Austen made by her sister has been loaned to the museum
Emily Brontë is a journalist and feature writer specialising in culture, entertainment, literature, and current affairs. She is dedicated to producing clear, accurate reporting that helps readers stay informed about developments in the UK and around the world.
